about
Circulating microRNAs: macro-utility as markers of prostate cancer?Vps75, a new yeast member of the NAP histone chaperone family.Interacting partners of the Tfb2 subunit from yeast TFIIH.Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistenceFunctional studies of the yeast med5, med15 and med16 mediator tail subunits.Identification and characterization of a host reversibly glycosylated peptide that interacts with the Tomato leaf curl virus V1 protein.MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4.Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtypeTargeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapiesExpression of androgen receptor splice variants in clinical breast cancers.Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors.Transcript Elongation by RNA Polymerase II.Epithelial plasticity in prostate cancer: principles and clinical perspectives.An rtt109-independent role for vps75 in transcription-associated nucleosome dynamics.MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer.Identification of androgen receptor splice variant transcripts in breast cancer cell lines and human tissues.MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers.An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity.Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of PlayCell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome.A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.Genome-wide mapping of ZNF652 promoter binding sites in breast cancer cells.Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation.Erratum to: IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptorInteraction with a host ubiquitin-conjugating enzyme is required for the pathogenicity of a geminiviral DNA beta satellite.Single-stranded DNA of Tomato leaf curl virus accumulates in the cytoplasm of phloem cells.A NAC domain protein interacts with tomato leaf curl virus replication accessory protein and enhances viral replication.Host responses to transient expression of individual genes encoded by Tomato leaf curl virus.Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer.Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion.
P50
Q27000024-493E3C92-AA40-4D35-8479-5AD95CFC82DBQ27931921-4EF8CE14-E64E-49D8-8DC3-23B1FC391C36Q27934685-C5213BDD-D95E-4AA8-ADF4-8594174A68B0Q28076090-7A4CD768-6ADA-450C-989A-583BB5A164E2Q31133536-BD876427-CFEB-4E6C-AC5B-56D791924573Q33247296-F279909E-2A74-4988-9896-0B403EE9FF9DQ33728193-2967C348-87DD-4F88-B7DC-C300B5F3701DQ33835918-BEBBD429-698A-43AA-BBF3-543B0EA44F6CQ34230017-41DE1C9E-296D-4000-82A2-119113C79461Q35820376-FA4F68E7-15DA-4F9F-8397-EF9812DA0D18Q35842471-0D04AB58-6DC9-4A7C-84FF-85B02BF6FE83Q36689084-FF8B35BF-4100-4FE8-9D29-F50AD7CF3D94Q36849142-95562D16-A125-4695-8A8C-9466D097B275Q37093536-1AD5C6D9-1080-4C20-B8BD-3D846D6A58E5Q37724162-EFE6CAD7-61F2-4037-841F-8D3D52EA2E36Q38254931-24B72DD7-3C0E-44A1-899C-8DC6651DCF77Q38353754-03C61E75-C4E2-480F-9BBF-64944167BE0EQ38724560-284D21E1-FE5F-4D1D-9787-61CBD69000BBQ38740513-ED07529E-865F-46C6-BF0E-E85A1A75C036Q38753546-8BBC8257-4BE7-4410-BD4C-56DA26342A3DQ38766156-918D4D8D-8D0D-4768-BCE1-9A4B28939AD2Q38910928-1B67CA56-8675-451A-B1CE-E15976216ABCQ39020826-9844B070-A12B-4817-8F9A-BCD17B61062EQ39095883-820B126F-3A43-4F2E-BF53-431C8BB744FFQ39316736-7937DCE1-DDE4-410E-9A69-6168052FA19FQ39327555-EC292A0D-5DE8-4EBC-832A-A741DD0171ADQ39375743-82C231D8-F0FA-43AF-BD2D-043C5ECB71C6Q39383629-2E10F0A1-4C99-47AE-8148-CFA8C78AFF6FQ39406777-BE75AC75-A7D7-4630-8F85-5AB00C5AED70Q39523591-6EEA0C08-7E24-4034-B7C2-6A7ADC678BB9Q42439577-563C205F-B35E-4390-99FC-E5FE7F5D46C5Q42631285-789D1908-23D2-4773-88A2-3A1F32CB2437Q43510727-61EB70D7-0A48-4ACF-A5E7-62F93C47FD84Q44007314-E83EEF47-9461-4E08-ADE1-FE3E6F829D11Q45533299-57FF2CD4-B047-438A-B876-58A1C845AF61Q45700228-5BD96EEB-05EC-4C9A-B845-B594AE6EA677Q47281377-0B5C836C-1480-4E41-98B3-3079D2EAD790Q47696958-F935131E-3278-4CC9-94BF-A3320A48BDCBQ47805050-D53469F9-09A7-49A5-A169-5EEDF53226C6Q48121004-420D6669-8EFC-4F24-BFE6-1513D0CA8DA5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luke A Selth
@nl
Luke A Selth
@sl
Luke A. Selth
@en
Luke A. Selth
@es
type
label
Luke A Selth
@nl
Luke A Selth
@sl
Luke A. Selth
@en
Luke A. Selth
@es
prefLabel
Luke A Selth
@nl
Luke A Selth
@sl
Luke A. Selth
@en
Luke A. Selth
@es
P106
P1153
6507305294
P1960
IfXWSaQAAAAJ
P21
P31
P496
0000-0002-4686-1418